These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15156429)

  • 1. Addressing the need for treatment paradigms for drug-abusing patients with multiple morbidities.
    Kresina TF; Normand J; Khalsa J; Mitty J; Flanigan T; Francis H
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S398-401. PubMed ID: 15156429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R; Singla V; Kacharya Sk
    Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical illness and comorbidities in drug users: implications for addiction pharmacotherapy treatment.
    Draper JC; McCance-Katz EF
    Subst Use Misuse; 2005; 40(13-14):1899-921, 2043-8. PubMed ID: 16282085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of community-based, directly observed therapy for HIV infection: lessons learned for treatment of hepatitis C virus infection.
    Flanigan TP; Taylor LE; Mitty JA
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S346-8. PubMed ID: 15768346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users.
    Neaigus A; Gyarmathy VA; Zhao M; Miller M; Friedman SR; Des Jarlais DC
    J Infect Dis; 2007 Apr; 195(7):1052-61. PubMed ID: 17330797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical management of HIV-hepatitis C virus coinfection in injection drug users.
    Khalsa JH; Kresina T; Sherman K; Vocci F
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S1-6. PubMed ID: 16265605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexually transmitted disease among women with HIV infection: a missed opportunity for intervention.
    Wilson TE; Augenbraun M
    AIDS Read; 1999 Nov; 9(8):573-7. PubMed ID: 11082735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population.
    Hwang LY; Kramer JR; Troisi C; Bull L; Grimes CZ; Lyerla R; Alter MJ
    Hepatology; 2006 Aug; 44(2):341-51. PubMed ID: 16871571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug users: a potentially important bridge population in the transmission of sexually transmitted diseases, including AIDS, in China.
    Liu H; Grusky O; Li X; Ma E
    Sex Transm Dis; 2006 Feb; 33(2):111-7. PubMed ID: 16432483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric barriers to readiness for treatment for hepatitis C Virus (HCV) infection among injection drug users: clinical experience of an addiction psychiatrist in the HIV-HCV coinfection clinic of a public health hospital.
    Scheft H; Fontenette DC
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S292-6. PubMed ID: 15768337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivering therapy for hepatitis C virus infection to incarcerated HIV-seropositive patients.
    McGovern B; Fiore J; Wurcel A; Taglienti P; Bradley M; Galvin S; Libone G; Ramsey J; Molinaro-Gudas V; Drewniak S; Amick C; Andalkar A; Scheft H; Bica I
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S56-62. PubMed ID: 16265615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of prevention programmes for HIV, hepatitis and sexually transmitted infections among migrants consulting in the doctors of the World French centers].
    Pauti MD; Simonnot N; Estecahandy P
    Med Mal Infect; 2008 Sep; 38(9):495-9. PubMed ID: 18706782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral hepatitis and HIV coinfection.
    Sulkowski MS
    J Hepatol; 2008 Feb; 48(2):353-67. PubMed ID: 18155314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV.
    Kresina TF; Bruce RD; Cargill VA; Cheever LW
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S83-8. PubMed ID: 16265621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care.
    Fireman M; Indest DW; Blackwell A; Whitehead AJ; Hauser P
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S286-91. PubMed ID: 15768336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexually transmitted diseases: advances in diagnosis and treatment.
    Quinn TC; Zenilman J; Rompalo A
    Adv Intern Med; 1994; 39():149-96. PubMed ID: 8140954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.